Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
批准号:
7586638
负责人:
Zhenyu Yue
金额:
$37.08万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-03-31
关键词:
1-Phosphatidylinositol 3-KinaseAgeAnimal ModelAutophagocytosisAutophagosomeAxonAxonal TransportCell physiologyCellsCessation of lifeCommunicable DiseasesCytoplasmDevelopmentDiseaseDopamineDrug Delivery SystemsEatingEvaluationExcisionGoalsHomeostasisHumanLewy BodiesLinkLysosomesMaintenanceMalignant NeoplasmsMediatingMembraneMicrotubulesMidbrain structureMolecularMutant Strains MiceNerve DegenerationNeurodegenerative DisordersNeuronsOxidative StressParkinson DiseasePathogenesisPathologic ProcessesPathway interactionsPhosphotransferasesPhysiologicalPhysiological ProcessesPresynaptic TerminalsPreventionProcessProductionProteinsRegulationRoleTestingTherapeuticVacuoleValidationage relatedaxonopathybasedopaminergic neuronhuman diseasein vivoinsightmouse modelmutantnervous system disorderprotein complexpublic health relevancesynuclein
中文摘要
描述(由申请人提供):大自噬(自噬)是一种受调节的细胞“自噬”过程,其将一部分细胞质隔离到双膜空泡(自噬体)中,并将自噬体递送到溶酶体进行降解。自噬通路与多种生理过程以及人类病理状态如癌症、传染病、衰老和神经变性有关。我们的长期目标是阐明神经元自噬的分子和细胞过程,了解神经退行性疾病的致病机制的自噬失调的分子基础,并评估自噬作为治疗目的的药物靶点。最近的研究,包括我们的研究,已经证明神经细胞含有基础水平的自噬,并且这种组成性自噬具有神经保护作用。我们最近的研究还揭示了一个重要的,以前未被认识到的细胞自主功能的自噬在预防轴突营养不良和变性。我们的主要假设是,自噬活动是高度区室化的神经元,并在轴突的具体调节。基于我们的研究结果,轴突自噬是不可缺少的,在生理条件下的轴突稳态的维持,我们还假设,受损的轴突自噬可以有助于轴突病,这是与一些人类神经系统疾病。此外,目前的证据已经将自噬途径与细胞中易聚集蛋白(如1-突触核蛋白A53 T突变体)的降解和预防毒性积累联系起来。我们进一步假设,自噬活性可以修改疾病的过程中,多巴胺能神经元的缺陷易患帕金森氏病的发病机制。因此,我们的具体目标是:(1)研究轴突中神经元的自噬过程及其调控机制;(2)研究轴突中疾病相关蛋白的自噬清除及其干扰轴突自噬的潜在致病机制;(3)确定自噬缺陷促进中脑多巴胺能神经元中与年龄相关的1-突触核蛋白的毒性积累、氧化应激和神经元死亡。我们的研究将有助于深入了解神经元或轴突中的自噬过程及其调控机制,为理解轴突病的发病机制和评价自噬作为治疗帕金森病等神经退行性疾病的药物靶点提供有价值的信息。公共卫生相关性:本项目的目标是阐明神经元自噬的分子和细胞过程,它与神经退行性疾病的致病机制有关。我们将研究功能失调的自噬如何与帕金森病的病理过程联系起来,并进一步评估自噬作为治疗帕金森病的药物靶点。
英文摘要
DESCRIPTION (provided by applicant): Macroautophagy (autophagy) is a regulated, cellular "self-eating" process that sequesters a portion of cytoplasm into double membrane vacuoles (autophagosomes) and delivers autophagosomes to lysosomes for degradation. Autophagic pathway has previously been implicated in a variety of physiological processes as well as human pathological conditions such as cancer, infectious diseases, ageing and neurodegeneration. Our long-term goal is to elucidate the molecular and cellular process of neuronal autophagy, to understand molecular basis of deregulated autophagy which underlies the pathogenic mechanisms of neurodegenerative diseases, and to evaluate autophagy as drug target for therapeutic purpose. Recent studies, including ours, have demonstrated that neural cells contain basal level of autophagy and that this constitutive autophagy is neuro-protective. Our recent study has also revealed an important, previously unrecognized cell-autonomous function of autophagy in the prevention of axonal dystrophy and degeneration. Our primary hypothesis is that autophagic activity is highly compartmentalized in neuron and is specifically regulated in the axons. Based our findings that axonal autophagy is indispensable for the maintenance of axonal homeostasis under physiological condition, we also hypothesize that compromised axonal autophagy can contribute to the axonopathies which are associated with a number of human neurological disorders. Moreover, current evidence has linked autophagic pathway to the degradation and prevention of toxic accumulation of aggregate-prone proteins (such as 1-synuclein A53T mutant) in the cells. We further hypothesize that autophagic activity can modify the disease process and that deficiency in dopaminergic neurons predisposes to the pathogenesis of Parkinson's disease. Thus, our specific aims are to (1) dissect neuronal autophagic process in the axons and control mechanism of axonal autophagy; (2) investigate the autophagic clearance of disease-associated proteins from the axons and potential pathogenic mechanism mediated by disease-associated proteins in perturbing axonal autophagy; (3) determine that deficiency in autophagy promote the age-related toxic accumulation of 1-synuclein, oxidative stress and neuronal death in the midbrain dopaminergic neurons. Our proposal is expected to provide insight into specific autophagic process and the regulation of autophagy in neuron or axons, and will provide valuable information for the understanding of pathogenic mechanism of axonopathy and the evaluation of autophagy as drug target for the treatment of neurodegenerative disease such as Parkinson's disease. PUBLIC HEALTH RELEVANCE: The goal of this project is to elucidate the molecular and cellular process of neuronal autophagy which has been implicated in the pathogenic mechanisms of neurodegenerative diseases. We will investigate how dysfunctional autophagy is connected to the pathological process in Parkinson's disease and further evaluate autophagy as drug target for the treatment of Parkinson's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering LRRK2 pathophysiology in mediating gut-brain axis of PD using novel genetic mouse models
-
批准号:10284434
-
项目类别:
-
资助金额:$15.89万
-
财政年份:2021
-
负责人:Zhenyu Yue
-
依托单位:
Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease
-
批准号:10581646
-
项目类别:
-
资助金额:$84.22万
-
财政年份:2021
-
负责人:Zhenyu Yue
-
依托单位:
Administrative management of Mount Sinai PD consortium
-
批准号:10284433
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2021
-
负责人:Zhenyu Yue
-
依托单位:
Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease
-
批准号:10430042
-
项目类别:
-
资助金额:$84.22万
-
财政年份:2021
-
负责人:Zhenyu Yue
-
依托单位:
Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease
-
批准号:10213290
-
项目类别:
-
资助金额:$84.36万
-
财政年份:2021
-
负责人:Zhenyu Yue
-
依托单位:
Determining Selective Autophagy Kinase in Modulating Neurotoxicity in Huntington's Disease Model
-
批准号:10656193
-
项目类别:
-
资助金额:$46.79万
-
财政年份:2020
-
负责人:Zhenyu Yue
-
依托单位:
Determining selective autophagy kinase in modulating neurotoxicity in Huntington's disease model
-
批准号:10033925
-
项目类别:
-
资助金额:$46.79万
-
财政年份:2020
-
负责人:Zhenyu Yue
-
依托单位:
Determining selective autophagy kinase in modulating neurotoxicity in Huntington's disease model
-
批准号:10438575
-
项目类别:
-
资助金额:$46.79万
-
财政年份:2020
-
负责人:Zhenyu Yue
-
依托单位:
Determining selective autophagy kinase in modulating neurotoxicity in Huntington's disease model
-
批准号:10213157
-
项目类别:
-
资助金额:$46.79万
-
财政年份:2020
-
负责人:Zhenyu Yue
-
依托单位:
DISTINCT REGULATION OF AUTOPHAGIC ACTIVITY BY TWO NOVEL PROTEINS
-
批准号:8361544
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2011
-
负责人:Zhenyu Yue
-
依托单位:
DISTINCT REGULATION OF AUTOPHAGIC ACTIVITY BY TWO NOVEL PROTEINS
-
批准号:8169173
-
项目类别:
-
资助金额:$0.35万
-
财政年份:2010
-
负责人:Zhenyu Yue
-
依托单位:
DISTINCT REGULATION OF AUTOPHAGIC ACTIVITY BY TWO NOVEL PROTEINS
-
批准号:7954142
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2009
-
负责人:Zhenyu Yue
-
依托单位:
Molecular Mechanism of LRRK2 Biology and Pathology in Parkinson's Disease
-
批准号:9058614
-
项目类别:
-
资助金额:$45.61万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
-
批准号:7846239
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
-
批准号:10083233
-
项目类别:
-
资助金额:$58.3万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
-
批准号:10308696
-
项目类别:
-
资助金额:$58.3万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
A NOVEL ROLE OF AUTOPHAGY IN AXONAL DYSTROPHY AND DEGENERATION
-
批准号:7722210
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
Using BAC-transgenic and Proteomic Approach to Study LRRK2 Biology and Pathology
-
批准号:7935385
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
Using BAC-transgenic and Proteomic Approach to Study LRRK2 Biology and Pathology
-
批准号:7643112
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
Using BAC-transgenic and Proteomic Approach to Study LRRK2 Biology and Pathology
-
批准号:8047698
-
项目类别:
-
资助金额:$3.34万
-
财政年份:2008
-
负责人:Zhenyu Yue
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: